日本新增76人疑因服用小林制药红曲保健品死亡
中新社东京6月28日电（记者 朱晨曦）近日，日本小林制药公司所产的红曲保健品引发广泛关注。据日本广播协会电视台报道，日本厚生劳动省最新数据显示，疑似因服用该公司红曲保健品导致健康受损甚至死亡的消费者数量持续上升。
据了解，本次新增疑似因服用该红曲保健品死亡的消费者达到76人。这一数字令人震惊，也再次引发公众对公司产品质量的质疑。此前已有相关报告指出，部分消费者反映服用该红曲保健品后出现身体不适等症状。
目前，日本厚生劳动省正在对此事进行深入调查，并呼吁消费者暂停使用小林制药公司的红曲保健品。同时，该省也已要求小林制药公司提供相关产品的详细资料，以便查明原因，避免更多消费者受到损害。
在此事件中，消费者的健康安全至关重要。对于小林制药公司而言，积极应对、主动承担责任、尽快解决问题是其应有的社会责任。同时，提醒广大消费者要关注自身健康，遵循医嘱，慎重选择保健品。
日本社会各界正密切关注此事的进展，将根据实际调查情况采取相应的措施。
英语如下：
Title of the news: “New 76 deaths suspected to be caused by Kobayashiyama Pharmaceutical’s Red Yeast Rice Supplements in Japan, Health Crisis Hits Again”
Keywords: Kobayashiyama Pharmaceutical Red Yeast Rice Supplements, increasing number of deaths, Japanese Ministry of Health, Labor and Welfare
News content:
Tokyo, June 28 (China News Service) (Reporter Zhu Chenxi) Recently, the red yeast rice supplements produced by the Japanese Kobayashiyama Pharmaceutical Company have attracted widespread attention. According to the Japanese Broadcasting Corporation, the latest data from the Japanese Ministry of Health, Labor and Welfare shows that the number of consumers who are suspected of being harmed or even killed by the company’s red yeast rice supplements continues to rise.
It is understood that 76 new deaths are suspected to be caused by the red yeast rice supplements. This figure is shocking and once again raises public doubts about the quality of the company’s products. Previously, there have been reports that some consumers have reported experiencing physical discomfort after taking the red yeast rice supplements.
Currently, the Japanese Ministry of Health, Labor and Welfare is conducting a thorough investigation into this matter and is urging consumers to suspend using Kobayashiyama Pharmaceutical’s red yeast rice supplements. At the same time, the ministry has also requested Kobayashiyama Pharmaceutical to provide detailed information on the products in order to identify the cause and avoid harming more consumers.
In this incident, the health and safety of consumers are of paramount importance. For Kobayashiyama Pharmaceutical, actively responding, taking responsibility, and resolving the problem as soon as possible are their social responsibilities. At the same time, it reminds consumers to pay attention to their own health, follow doctors’ advice, and choose health supplements carefully.
Japanese society is paying close attention to the progress of this matter and will take appropriate measures based on actual investigation results.
【来源】http://www.chinanews.com/gj/2024/06-28/10242662.shtml
Views: 1